Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-
resorptive medications. Despite its low incidence rate, this problem has gained attention in …

Introduction Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a pathologic
condition of increasing frequency, with a poorly understood pathophysiology and which can …

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is defined as an exposed
necrotic bone in the oral cavity that does not heal after appropriate intervention for> 8 weeks …

Locally applied bisphosphonates may improve the fixation of metal implants in bone.
However, systemic bisphosphonate treatment is associated with a risk of osteonecrosis of …

Objectives To establish osteonecrosis of the jaws in rats treated with different doses of
zoledronic acid (ZA). Methods Male Wistar rats (n= 6–7) received three consecutive weekly …

Bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) is a serious and challenging
complication of chronic BP uptake in patients with osteoporosis who require management of …

Objective This study was performed to determine whether the results of prevailing in vivo
and in vitro studies offer a reliable model for investigation of medication-related …

Numerous factors can affect skeletal regeneration, including the extent of bone injury,
mechanical loading, inflammation and exogenous molecules. Bisphosphonates are …

PURPOSE: Osteonecrosis of the jaws is a well-known condition associated with long-term
bisphosphonate use. This study analyzed the prophylactic effect of antibiotic treatment in …